Boel Brynedal

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2024;:S0002-9378(24)00087-5

Mode of delivery and subsequent self-perceived sexual life satisfaction: a population-based cohort study.

Larsdotter Zweygberg A; Martin FZ; Brynedal B; Storck Lindholm E; Kosidou K; Ahlqvist VH; Magnusson C
Article: ENVIRONMENTAL RESEARCH. 2023;239(Pt 1):117230

Multiple myeloma risk in relation to long-term air pollution exposure - A pooled analysis of four European cohorts.

Hvidtfeldt UA; Chen J; Rodopoulou S; Strak M; de Hoogh K; Andersen ZJ; Bellander T; Brandt J; Forastiere F; Brynedal B; Hertel O; Hoffmann B; Katsouyanni K; Ketzel M; Leander K; Magnusson PKE; Nagel G; Pershagen G; Rizzuto D; Samoli E; So R; Stafoggia M; Tjønneland A; Weinmayr G; Wolf K; Zitt E; Brunekreef B; Hoek G; Raaschou-Nielsen O
Article: BJPSYCH OPEN. 2023;9(6):e205

Migration background, eating disorder symptoms and healthcare service utilisation: findings from the Stockholm Public Health Cohort.

Strand M; Bäärnhielm S; Fredlund P; Brynedal B; Welch E
Article: SCIENTIFIC REPORTS. 2023;13(1):10058

Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs.

Hedman ÅK; Winter E; Yoosuf N; Benita Y; Berg L; Brynedal B; Folkersen L; Klareskog L; Maciejewski M; Sirota-Madi A; Spector Y; Ziemek D; Padyukov L; Shen-Orr SS; Jelinsky SA
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2023;32(1):105-113

Breast Cancer Incidence in Relation to Long-Term Low-Level Exposure to Air Pollution in the ELAPSE Pooled Cohort.

Hvidtfeldt UA; Chen J; Rodopoulou S; Strak M; de Hoogh K; Andersen ZJ; Bellander T; Brandt J; Fecht D; Forastiere F; Gulliver J; Hertel O; Hoffmann BH; Katsouyanni K; Ketzel M; Brynedal B; Leander K; Ljungman PLS; Magnusson PKE; Nagel G; Pershagen G; Rizzuto D; Boutron-Ruault M-C; Samoli E; So R; Stafoggia M; Tjønneland A; Vermeulen R; Verschuren WMM; Weinmayr G; Wolf K; Zhang J; Zitt E; Brunekreef B; Hoek G; Raaschou-Nielsen O
Article: FRONTIERS IN MEDICINE. 2023;10:1146353

Molecular signature of methotrexate response among rheumatoid arthritis patients.

Brynedal B; Yoosuf N; Ulfarsdottir TB; Ziemek D; Maciejewski M; Folkersen L; Westerlind H; Müller M; Sahlström P; Jelinsky SA; Hensvold A; Padyukov L; Pomiano NV; Catrina A; Klareskog L; Berg L
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2022;51(6):e401-e413

Cohort Profile: The Stockholm Diabetes Prevention Programme (SDPP).

Gudjonsdottir H; Tynelius P; Fors S; Yacamán Méndez D; Gebreslassie M; Zhou M; Carlsson AC; Svefors P; Wändell P; Östenson C-G; Brynedal B; Lager A
Article: BMC MEDICINE. 2022;20(1):356

Characterization of data-driven clusters in diabetes-free adults and their utility for risk stratification of type 2 diabetes.

Yacamán Méndez D; Zhou M; Trolle Lagerros Y; Gómez Velasco DV; Tynelius P; Gudjonsdottir H; Ponce de Leon A; Eeg-Olofsson K; Östenson C-G; Brynedal B; Aguilar Salinas CA; Ebbevi D; Lager A
Article: ENVIRONMENT INTERNATIONAL. 2022;166:107341

Exposure to surrounding greenness and natural-cause and cause-specific mortality in the ELAPSE pooled cohort.

Bereziartua A; Chen J; de Hoogh K; Rodopoulou S; Andersen ZJ; Bellander T; Brandt J; Fecht D; Forastiere F; Gulliver J; Hertel O; Hoffmann B; Arthur Hvidtfeldt U; Verschuren WMM; Jöckel K-H; Jørgensen JT; Katsouyanni K; Ketzel M; Hjertager Krog N; Brynedal B; Leander K; Liu S; Ljungman P; Faure E; Magnusson PKE; Nagel G; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rizzuto D; Samoli E; van der Schouw YT; Schramm S; Severi G; Stafoggia M; Strak M; Sørensen M; Tjønneland A; Weinmayr G; Wolf K; Zitt E; Brunekreef B; Hoek G
Article: RHEUMATOLOGY. 2022;61(4):1680-1689

Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis.

Yoosuf N; Maciejewski M; Ziemek D; Jelinsky SA; Folkersen L; Müller M; Sahlström P; Vivar N; Catrina A; Berg L; Klareskog L; Padyukov L; Brynedal B
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:804822

Antibodies to a Citrullinated Porphyromonas gingivalis Epitope Are Increased in Early Rheumatoid Arthritis, and Can Be Produced by Gingival Tissue B Cells: Implications for a Bacterial Origin in RA Etiology.

Sherina N; de Vries C; Kharlamova N; Sippl N; Jiang X; Brynedal B; Kindstedt E; Hansson M; Mathsson-Alm L; Israelsson L; Stålesen R; Saevarsdottir S; Holmdahl R; Hensvold A; Johannsen G; Eriksson K; Sallusto F; Catrina AI; Rönnelid J; Grönwall C; Yucel-Lindberg T; Alfredsson L; Klareskog L; Piccoli L; Malmström V; Amara K; Lundberg K
Article: MULTIPLE SCLEROSIS JOURNAL. 2021;27(7):1014-1026

Methylome and transcriptome signature of bronchoalveolar cells from multiple sclerosis patients in relation to smoking.

Ringh MV; Hagemann-Jensen M; Needhamsen M; Kullberg S; Wahlström J; Grunewald J; Brynedal B; Jagodic M; Ekström TJ; Öckinger J; Kular L
Article: PLOS ONE. 2021;16(4):e0250282

Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations.

Diaz-Gallo L-M; Brynedal B; Westerlind H; Sandberg R; Ramsköld D
Article: ARTHRITIS RESEARCH & THERAPY. 2020;22(1):170

Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.

Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson P-J; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2019;105(3):616-624

Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype.

Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Lundberg K; Skriner K; Serre G; Rönnelid J; Mathsson-Alm L; Brink M; Dahlqvist SR; Padyukov L; Gregersen PK; Barton A; Alfredsson L; Klareskog L; Raychaudhuri S
Article: EBIOMEDICINE. 2019;46:290-304

Tobacco smoking induces changes in true DNA methylation, hydroxymethylation and gene expression in bronchoalveolar lavage cells.

Ringh MV; Hagemann-Jensen M; Needhamsen M; Kular L; Breeze CE; Sjöholm LK; Slavec L; Kullberg S; Wahlström J; Grunewald J; Brynedal B; Liu Y; Almgren M; Jagodic M; Öckinger J; Ekström TJ
Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(10):1454-1462

Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis.

Diaz-Gallo L-M; Ramsköld D; Shchetynsky K; Folkersen L; Chemin K; Brynedal B; Uebe S; Okada Y; Alfredsson L; Klareskog L; Padyukov L
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2017;100(4):581-591

Large-Scale trans-eQTLs Affect Hundreds of Transcripts and Mediate Patterns of Transcriptional Co-regulation.

Brynedal B; Choi J; Raj T; Bjornson R; Stranger BE; Neale BM; Voight BF; Cotsapas C
Article: GUT. 2017;66(3):421-428

Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis.

Westerlind H; Mellander M-R; Bresso F; Munch A; Bonfiglio F; Assadi G; Rafter J; Hübenthal M; Lieb W; Källberg H; Brynedal B; Padyukov L; Halfvarson J; Törkvist L; Bjork J; Andreasson A; Agreus L; Almer S; Miehlke S; Madisch A; Ohlsson B; Löfberg R; Hultcrantz R; Franke A; D'Amato M
Article: MOLECULAR MEDICINE. 2016;22:322-328

Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study.

Folkersen L; Brynedal B; Diaz-Gallo LM; Ramsköld D; Shchetynsky K; Westerlind H; Sundström Y; Schepis D; Hensvold A; Vivar N; Eloranta M-L; Rönnblom L; Brunak S; Malmström V; Catrina A; Moerch UG; Klareskog L; Padyukov L; Berg L
Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(Suppl 2):146

OP0234 Rheumatoid Arthritis Subsets Defined by Sub-Specificities of Anti-Citrullinated Antibodies (ACPAS) Have Unique HLA Associations

Brynedal B; Terao C; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Skriner K; Serre G; Rönnelid J; Padyukov L; Gregersen P; Worthington J; Alfredsson L; Raychaudhuri S; Klareskog L
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(4):762-768

Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis.

Maehlen MT; Olsen IC; Andreassen BK; Viken MK; Jiang X; Alfredsson L; Källberg H; Brynedal B; Kurreeman F; Daha N; Toes R; Zhernakova A; Gutierrez-Achury J; de Bakker PIW; Martin J; Teruel M; Gonzalez-Gay MA; Rodríguez-Rodríguez L; Balsa A; Uhlig T; Kvien TK; Lie BA
Journal article: NEUROLOGY. 2014;82(10_supplement)

HLA Genes and Interferon-beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis (P1.213)

Fink K; Link J; Lundkvist M; Hermanrud C; Lima I; Brynedal B; Kockum I; Hillert J; Fogdell-Hahn A
Article: PLOS ONE. 2014;9(3):e90479

Human leukocyte antigen genes and interferon beta preparations influence risk of developing neutralizing anti-drug antibodies in multiple sclerosis.

Link J; Lundkvist Ryner M; Fink K; Hermanrud C; Lima I; Brynedal B; Kockum I; Hillert J; Fogdell-Hahn A
Article: PLOS ONE. 2012;7(5):e36779

Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis.

Link J; Kockum I; Lorentzen AR; Lie BA; Celius EG; Westerlind H; Schaffer M; Alfredsson L; Olsson T; Brynedal B; Harbo HF; Hillert J
Article: JOURNAL OF NEUROIMMUNOLOGY. 2011;237(1-2):98-100

No influence on disease progression of non-HLA susceptibility genes in MS.

Lundström W; Greiner E; Lundmark F; Westerlind H; Smestad C; Lorentzen AR; Kockum I; Link J; Brynedal B; Celius EG; Harbo HF; Masterman T; Hillert J
Journal article: FUTURE NEUROLOGY. 2011;6(4):511-519

Entering a new phase of multiple sclerosis genetic epidemiology

Brynedal B; Hillert J
Article: JOURNAL OF IMMUNOLOGY. 2011;186(3):1338-1342

Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.

Joller N; Hafler JP; Brynedal B; Kassam N; Spoerl S; Levin SD; Sharpe AH; Kuchroo VK
Article: JOURNAL OF NEUROIMMUNOLOGY. 2010;226(1-2):172-176

Two HLA class I genes independently associated with multiple sclerosis.

Link J; Lorentzen AR; Kockum I; Duvefelt K; Lie BA; Celius EG; Harbo HF; Hillert J; Brynedal B
Article: GENES AND IMMUNITY. 2010;11(5):397-405

IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci.

International Multiple Sclerosis Genetics Conssort
Article: JOURNAL OF NEUROIMMUNOLOGY. 2010;220(1-2):120-124

MGAT5 alters the severity of multiple sclerosis.

Brynedal B; Wojcik J; Esposito F; Debailleul V; Yaouanq J; Martinelli-Boneschi F; Edan G; Comi G; Hillert J; Abderrahim H
Article: NEUROBIOLOGY OF DISEASE. 2010;37(3):613-621

Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?

Brynedal B; Khademi M; Wallström E; Hillert J; Olsson T; Duvefelt K
Article: RESPIRATORY RESEARCH. 2010;11(1):25

Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients.

Grunewald J; Brynedal B; Darlington P; Nisell M; Cederlund K; Hillert J; Eklund A
Article: JOURNAL OF INTERNAL MEDICINE. 2008;264(5):433-441

A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Löfgren's syndrome.

Spagnolo P; Sato H; Grunewald J; Brynedal B; Hillert J; Mañá J; Wells AU; Eklund A; Welsh KI; du Bois RM
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2007;14(8):835-840

The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.

Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
Article: PLOS ONE. 2007;2(7):e664

HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.

Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J
Article: JOURNAL OF NEUROIMMUNOLOGY. 2005;167(1-2):210-214

Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis.

Thangarajh M; Masterman T; Rot U; Duvefelt K; Brynedal B; Karrenbauer VD; Hillert J
Visa fler

Alla övriga publikationer

Preprint: RESEARCH SQUARE. 2022

Peripheral blood cellular dynamics of Rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs

Jelinsky SA; Hedman ÅK; Winter E; Yoosuf N; Benita Y; Berg L; Brynedal B; Folkersen L; Klareskog L; Maciejewski M; Sirota-Madi A; Spector Y; Ziemek D; Padyukov L; Shen-Orr SS
Preprint: MEDRXIV. 2021

Identification of loci genetically associated with antibodies to specific sets of citrullinated peptides in rheumatoid arthritis patients

Shchetynsky K; Brynedal B; Ramsköld D; Israelsson L; Hansson M; Mathsson-Alm L; Rönnelid J; Viatte S; Holmdahl R; Catrina A; Alfredsson L; Malmström V; Klareskog L; Gomez-Cabrero D; Padyukov L; Rheumatoid Arthritis Consortium International (RAC
Preprint: RESEARCH SQUARE. 2021

Early Prediction of Clinical Response to Anti-TNF Treatment using Multi-omics and Machine Learning in Rheumatoid Arthritis

Yoosuf N; Maciejewski M; Ziemek D; Jelinsky SA; Folkersen L; Müller M; Sahlström P; Vivar N; Catrina A; Berg L; Klareskog L; Padyukov L; Brynedal B
Letter: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2020;38(5):1029-1030

Occupational physical workload and development of anti-collagen type II antibodies in rheumatoid arthritis: results from the Swedish EIRA population-based case-control study.

Zeng P; Pertsinidou E; Brynedal B; Manivel VA; Klareskog L; Mullazehi M; Saevarsdottir S; Bengtsson C; Alfredsson L; Rönnelid J
Preprint: RESEARCH SQUARE. 2020

Molecular Biomarkers of Anti-TNF Response in Patients with Rheumatoid Arthritis

Yoosuf N; Maciejewski M; Ziemek D; Jelinsky S; Folkersen L; Müller M; Sahlström P; Vivar N; Catrina A; Berg L; Klareskog L; Padyukov L; Brynedal B
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):583

Methylome and transcriptome signature of bronchoalveolar cells from multiple sclerosis patients in relation to smoking

Ringh M; Hagemann-Jensen M; Needhamsen M; Kullberg S; Wahlstrom J; Grunewald J; Brynedal B; Jagodic M; Ekstrom T; Ockinger J; Kular L
Corrigendum: AMERICAN JOURNAL OF HUMAN GENETICS. 2019;105(4):880

Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype.

Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Lundberg K; Skriner K; Serre G; Rönnelid J; Mathsson-Alm L; Brink M; Dahlqvist SR; Padyukov L; Gregersen PK; Barton A; Alfredsson L; Klareskog L; Raychaudhuri S
Preprint: BIORXIV. 2019

Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations

Diaz-Gallo L-M; Brynedal B; Westerlind H; Sandberg R; Ramsköld D
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:A13

OCCUPATIONAL PHYSICAL WORKLOAD AND DEVELOPMENT OF ANTI-COLLAGEN TYPE II ANTIBODIES IN RHEUMATOID ARTHRITIS: RESULTS FROM THE SWEDISH EIRA POPULATION-BASED CASE-CONTROL STUDY

Pertsinidou E; Zeng P; Brynedal B; Manivel VA; Klareskog L; Mullazehi M; Saevarsdottir S; Bengtsson C; Alfredsson L; Ronnelid J
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:A33

CHARACTERISATION OF THE ANTIBODY RESPONSE TO A CITRULLINATED PEPTIDE DERIVED FROM PORPHYROMONAS GINGIVALIS PAD IN RA

Kharlamova N; Brynedal B; Sherina N; Eriksson K; Lindberg T; Hansson M; Israelsson L; Steen J; Malmstrom V; Alfredsson L; Amara K; Lundberg K
Preprint: BIORXIV. 2017

The association between the HLA-DRB1 shared epitope alleles and the risk of rheumatoid arthritis is influenced by massive gene-gene interactions

Diaz-Gallo L-M; Ramsköld D; Shchetynsky K; Folkersen L; Chemin K; Brynedal B; Uebe S; Okada Y; Alfredsson L; Klareskog L; Padyukov L
Letter: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2016;111(8):1211-1213

HLA Associations Distinguish Collagenous From Lymphocytic Colitis.

Westerlind H; Bonfiglio F; Mellander M-R; Hübenthal M; Brynedal B; Björk J; Törkvist L; Padyukov L; Ohlsson B; Löfberg R; Hultcrantz R; Franke A; Bresso F; D'Amato M
Preprint: BIORXIV. 2016

Large-scale trans-eQTLs affect hundreds of transcripts and mediate patterns of transcriptional co-regulation Short: trans-eQTLs reveal patterns of transcriptional co-regulation

Brynedal B; Choi J; Raj T; Bjornson R; Stranger BE; Neale BM; Voight BF; Cotsapas C
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68

Specific Antibody Subphenotypes in Rheumatoid Arthritis Are Associated with Unique HLA-DRB1 Residues at Position 11

Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Mathsson-Alm L; Jakobsson PJ; Skriner K; Serre G; Ronnelid J; Padyukov L; Worthington J; Alfredsson L; Klareskog L; Raychaudhuri S
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68

Antibody Mediated Immunity Drives Response to Methotrexate Treatment in Rheumatoid Arthritis Patients

Brynedal B; Westerlind H; Folkersen L; Padyukov L; Vivar N; Catrina AI; Klareskog L; Berg L
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:435-436

Genetic load in eleven distantly related individuals from an MS high risk area

Imrell K; Masterman T; Brynedal B; Lima I; Hillert J; Kockum I; Landtblom A-M
Preprint: ARXIV. 2014

Cross-phenotype meta-analysis reveals large-scale trans-eQTLs mediating patterns of transcriptional co-regulation

Brynedal B; Raj T; Stranger BE; Bjornson R; Neale BM; Voight BF; Cotsapas C
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2014;79(6):450

Human Leucocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Antidrug Antibodies in Multiple Sclerosis

Ryner ML; Link J; Fink K; Hermanrud C; Lima I; Brynedal B; Kockum I; Hillert J; Fogdell-Hahn A
Conference publication: HLA. 2014;84(1):109

HUMAN LEUKOCYTE ANTIGEN GENES AND INTERFERON BETA PREPARATIONS INFLUENCE RISK OF DEVELOPING NEUTRALIZING ANTI-DRUG ANTIBODIES IN MULTIPLE SCLEROSIS

Link J; Ryner ML; Fink K; Hermanrud C; Lima I; Brynedal B; Kockum I; Hillert J; Fogdell-Hahn A
Conference publication: NEUROLOGY. 2012;78:p05.121

Investigation of the Effect of Human Leukocyte Antigen on the Development of Neutralizing Antibodies in Interferon-beta Treated Patients with Multiple Sclerosis (*The First Three Authors Contributed Equally to This Work)

Fink K; Lundkvist M; Link J; Kockum I; Hermanrud C; Brynedal B; Hillert J; Fogdell-Hahn A
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2012;19:361

Preparation-specific genetically determined risk of developing neutralizing antibodies towards interferon-beta in patients with multiple sclerosis

Link J; Fink K; Lundkvist M; Brynedal B; Kockum I; Fogdell-Hahn A; Hillert J
Conference publication: IMMUNOLOGY. 2012;137:663

Effect of HLA genotype on the development of neutralizing antibodies to interferon beta in patients with multiple sclerosis

Lundkvist M; Link J; Fink K; Hermanrud C; Brynedal B; Fogdell-Hahn A; Kockum I; Hillert J
Conference publication: JOURNAL OF NEUROLOGY. 2012;259:S149

HLA-DRB1*15 and HLA-A*02 are associated with higher risk of developing neutralising antibodies and clinically relevant titres against interferon-beta in multiple sclerosis

Link J; Lundkvist M; Fink K; Hermanrud C; Brynedal B; Fogdell-Hahn A; Kockum I; Hillert J
Conference publication: JOURNAL OF NEUROLOGY. 2011;258:196

Investigation of HLA genes in multiple sclerosis in Scandinavia

Link J; Kockum I; Lorentzen A; Lie BA; Celius EG; Schaffer M; Brynedal B; Harbo H; Hillert J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2011;17:S114

New evidence implicates IRF5 in the pathogenesis of multiple sclerosis

Bomfim IL; Wang C; Khademi M; Sandling J; Brynedal B; Lorentzen AR; Sondergaard HB; Oturai AB; Celius EG; Alfredsson L; Syvanen A-C; Kockum I; Olsson T; Hillert J
Editorial comment: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(23):E58

Differential expression, and genetic association, of CD58 in Swedish multiple sclerosis patients.

Brynedal B; Bomfim IL; Olsson T; Duvefelt K; Hillert J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2008;14:S189-S190

Human leukocyte antigen class I risks in multiple sclerosis: A rather than C

Link J; Lorentzen AR; Kockum I; Duvefelt K; Mero I-L; Celius EG; Harbo HF; Hillert J; Brynedal B
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2008;14:S60

Global expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?

Brynedal B; Khademi M; Wallstroem E; Hillert J; Olsson TP; Duvefelt K
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2007;14:22

The impact of HLA-A and HLA-DRB1 alleles on age at onset, disease course and severity in Scandinavian multiple sclerosis patients

Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
Conference publication: HLA. 2006;67(6):456

Genetic variation of HLA-A alters the susceptibility to multiple sclerosis

Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Hillert J
Visa fler

Anställningar

Epidemiolog, Epidemiologi och folkhälsa, Centrum för epidemiologi och samhällsmedicin, Region Stockholm, 2019-
Anknuten till Forskning, Global folkhälsa, Karolinska Institutet, 2021-2024

Examina och utbildning

Docent, epidemiologi, Karlinska Institutet, 2022
Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2009

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI